News. STudy Suggests DElta-Tocotrienol in Combination with Standard Therapy Increased Survival in Refractory Ovarian Cancer Patients

Study Suggests Delta-Tocotrienol in Combination with Standard Therapy Increased Survival in Refractory Ovarian Cancer PatientsA recent study conducted at Denmark’s Vejle Hospital, published in Pharmacological Research, provides evidence of delta-tocotrienol’s benefits...

Pin It on Pinterest